The global urinary incontinence market was valued at over $886 million in 2024 and is expected to grow at a CAGR of 4.4%, reaching over $1.2 billion by 2031.
Market Segments Covered:
Urethral Bulking Agents (UBAs)
Female Urinary Incontinence Slings
* Transvaginal Tape (TVT) Slings
* Transobturator (TOT) Slings
* Single-Incision Slings (SISs)
Male Implantable Devices
* Male Incontinence Slings
* Artificial Urinary Sphincters
Urinary Bags
* Bedside Bags
* Leg Bags
Comprehensive Market Insights
Market Size & Growth Trends
Unit Sales & Average Selling Prices
Procedure Numbers
Market Drivers & Limiters
Forecasts Until 2031 & Historical Data (2021-2023)
Competitive Market Share Insights
Recent Mergers & Acquisitions
Company Profiles & Product Portfolios
Global Urinary Incontinence Market Trends
Urinary incontinence slings dominate the market, accounting for the largest share of total market value.
Female urinary incontinence sling segment is recovering after past lawsuits, contributing to steady market growth.
Market Share Insights
Top Competitors in the Global Urinary Incontinence Market (2024):
1 Boston Scientific
* Market leader with strong performance in urethral bulking agents and incontinence slings.
2 Coloplast
* Second-largest market share, active in both male and female sling markets.
* Products: Aris(R), Altis(R), and Virtue(R) Male Sling.
3 Ethicon
* Third-largest competitor, leading in female urinary incontinence slings.